On Wednesday, Fitterfly, a digital health and therapeutics, announced to raise fund $12 million in Series A, which was led by Amazon Smbhav Venture Fund and Fireside Ventures. Existing investors also included named 9 Unicorns, Venture Catalysts and Nihar Parikh, who is the Founder of Health Ventures, and Sriram Natarajan who is the Founder of Molbio.

To increase Diabefly’s reach, their digital therapeutics and clinically proven programme. Also, to prevent and manage reverse diabetes. This fund is also used to enhance the technology stack to give unique clinical insights to FitterFly

• Stocks Under F&O Ban: Hindustan Copper, RBL Bank, and Others 
• Govt plans new route connecting Noida airport to NH-34
• India Ranks Third in Global Fintech Funding, Despite 33% Drop in 2024
• India’s Retail Inflation Drops to 5.22% in December, Food Inflation at 8.39%
• Donald Trump Inauguration: Xi Jinping Invited, S Jaishankar to Represent India

Dr Arbinder Singal, CEO and co-founder, of Fitterfly, said, “We want to take our clinically-proven diabetes and weight management system to the people who need it the most. This funding will help us strengthen our research, launch new verticals in the heart health space and grow our customer base by reaching out to people living with diabetes and the universe of doctors and organisations in the field of chronic disease management. Our corporate wellness models push the envelope from ‘tick-mark-based bundling’ to an ‘outcome-based approach’.”